Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Pain Therapeutics Inc (PTIE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Pain Therapeutics Inc (Pain Therapeutics) is a biopharmaceutical company which focuses on the development and commercialization of novel drugs for treating central nervous system disorders such as chronic pain. The company employs patented abuse-deterrent formulations (ADFs) for the treatment of pain. Its lead drug candidate, Remoxy (oxycodone) is a proprietary, abuse-deterrent, oral formulation of oxycodone (CII) that provides twelve hours of steady pain relief. The company is also developing an abuse-deterrent fentanyl skin patch to treat severe pain, a blood-based diagnostic to detect Alzheimer's disease (AD), and a proprietary small molecule drug for the treatment of AD. Pain Therapeutics is headquartered in Austin, Texas, the US.
Pain Therapeutics Inc Key Recent Developments
May 09,2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER
Feb 05,2018: Pain Therapeutics Reports Financial Results For 2017
Nov 01,2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results
Aug 09,2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update
Apr 25,2017: Pain Therapeutics Reports First Quarter 2017 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
Pain Therapeutics Inc-Key Facts 5
Pain Therapeutics Inc-Key Employees 6
Pain Therapeutics Inc-Key Employee Biographies 7
Pain Therapeutics Inc-Major Products and Services 8
Pain Therapeutics Inc-History 9
Pain Therapeutics Inc-Company Statement 11
Pain Therapeutics Inc-Locations And Subsidiaries 12
Head Office 12
Section 2-Company Analysis 13
Company Overview 13
Pain Therapeutics Inc-Business Description 14
Pain Therapeutics Inc-SWOT Analysis 15
SWOT Analysis-Overview 15
Pain Therapeutics Inc-Strengths 15
Pain Therapeutics Inc-Weaknesses 16
Pain Therapeutics Inc-Opportunities 17
Pain Therapeutics Inc-Threats 18
Pain Therapeutics Inc-Key Competitors 19
Section 3-Company Financial Ratios 20
Financial Ratios-Capital Market Ratios 20
Financial Ratios-Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios-Interim Ratios 24
Financial Ratios-Ratio Charts 25
Section 4-Company's Recent Developments 26
May 09, 2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER 26
Nov 01, 2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results 27
Aug 09, 2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update 28
Apr 25, 2017: Pain Therapeutics Reports First Quarter 2017 Financial Results 30
Feb 17, 2017: Pain Therapeutics Reports 2016 Financial Results 31
Section 5-Appendix 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
List of Figures
Pain Therapeutics Inc, Performance Chart (2013-2017) 23
Pain Therapeutics Inc, Ratio Charts 25
List of Tables
Pain Therapeutics Inc, Key Facts 5
Pain Therapeutics Inc, Key Employees 6
Pain Therapeutics Inc, Key Employee Biographies 7
Pain Therapeutics Inc, Major Products and Services 8
Pain Therapeutics Inc, History 9
Pain Therapeutics Inc, Key Competitors 19
Pain Therapeutics Inc, Ratios based on current share price 20
Pain Therapeutics Inc, Annual Ratios 21
Pain Therapeutics Inc, Annual Ratios (Cont...1) 22
Pain Therapeutics Inc, Interim Ratios 24
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35
Single User License:
Report can be used by individual purchaser only
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Teva Pharmaceutical Industries Ltd
Roxane Laboratories Inc
Endo Pharmaceuticals Inc
Purdue Pharma LP
Hikma Pharmaceuticals Plc
Pain Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
"Marketing Manager, Western Union Business Solutions"
"Sales Manager, Largest India Aesthetic Laser Manufacturer"
For Regular updates on our latest research reports